Brief: Freeline Therapeutics ADSS Open 2.8% Above IPO Price In Debut On Nasdaq
Aug 7 (Reuters) - Freeline Therapeutics Holdings PLC
FRLN.O :
* FREELINE THERAPEUTICS ADSS OPEN AT $18.50 IN DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $18.00/ADS
Further company coverage: FRLN.O
((Reuters.Briefs@thomsonreuters.com;))